Winslow Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed 107
2018
Q3
$0 Hold
1
﹤0.01% 102
2018
Q2
$0 Sell
1
-3
-75% -$249 ﹤0.01% 104
2018
Q1
$0 Sell
4
-432
-99% -$41.5K ﹤0.01% 103
2017
Q4
$46K Sell
436
-3,327,956
-100% -$376M ﹤0.01% 66
2017
Q3
$485M Sell
3,328,392
-227,487
-6% -$31M 2.61% 9
2017
Q2
$462M Sell
3,555,879
-690,423
-16% -$84.6M 2.46% 10
2017
Q1
$528M Sell
4,246,302
-1,194,816
-22% -$143M 2.52% 9
2016
Q4
$630M Buy
5,441,118
+245,968
+5% +$27.4M 2.9% 6
2016
Q3
$543M Sell
5,195,150
-146,105
-3% -$15.8M 2.26% 9
2016
Q2
$527M Buy
5,341,255
+931,307
+21% +$96.3M 2.15% 10
2016
Q1
$441M Sell
4,409,948
-1,972,580
-31% -$203M 1.73% 19
2015
Q4
$764M Sell
6,382,528
-613,909
-9% -$71M 2.73% 5
2015
Q3
$757M Buy
6,996,437
+283,645
+4% +$35.2M 2.76% 7
2015
Q2
$777M Sell
6,712,792
-573,432
-8% -$65.6M 2.58% 6
2015
Q1
$840M Sell
7,286,224
-506,988
-7% -$60.6M 2.59% 6
2014
Q4
$872M Sell
7,793,212
-2,120,874
-21% -$224M 2.69% 5
2014
Q3
$940M Sell
9,914,086
-963,804
-9% -$87M 2.87% 5
2014
Q2
$934M Sell
10,877,890
-625,942
-5% -$47.6M 2.85% 7
2014
Q1
$803M Sell
11,503,832
-1,230,014
-10% -$97.4M 2.51% 10
2013
Q4
$1.08B Buy
12,733,846
+2,317,346
+22% +$183M 3.17% 6
2013
Q3
$803M Sell
10,416,500
-1,120,284
-10% -$78.5M 2.6% 10
2013
Q2
$675M Buy
+11,536,784
New +$694M 2.2% 11

Other funds holding CELG

Winslow Capital Management's CELG Position: Q4 2018 in Review

Winslow Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 1 share.

Winslow Capital Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $1.08B in Q4 2013. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Winslow Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Winslow Capital Management sold 1 Celgene Corp share in Q4 2018.
  • Winslow Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Winslow Capital Management's Celgene Corp position peaked at $1.08B in Q4 2013.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Winslow Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.